Tranfusion Flashcards
Indications erythropheresis (6)
- Severe babebiosis
- Severe malaria
- Polycythemia vera
- SCD: life or organ-threatening complication
- SCD: stroke prevention
- SCD: prevention of iron overload
Indications leukapheresis (1)
Symptomatic hyperleucocytosis
Indications plasmapheresis (10)
- ABO incompatible HSCT
- ABO incompatible organ transplant
- TTP
- Myasthenia gravis
- PANDAS, severe
- Sydenham chorea, severe
- Acute Guillain-Barre syndrome
- Chronic inflammatory demyelinating polyneuropathy
- Goodpasture disease
- ANCA-associated glomerulonephritis (Wegener)
- Other indications exist*
Platelet refractoriness - differential diagnosis
Non-immune mechanisms: old platelet product, ABO-incompatibility, fever, sepsis, DIC, splenomegaly
Immune mechanisms: auto-Ab, alloimmunization
Patients at risk for TA-GVHD (5)
- Premature neonates
- Congenital immunodeficiency syndromes
- Patients receiving chemotherapy and/or radiation for malignancy
- Patients receiving immunosuppressive drugs after solid organ transplantation
- Patients receiving direct donations (heterozygous for HLA antigens)
Name clinically significant auto-Ab on erythrocytes, other than anti-AB and anti-D.
Anti-K Anti-E Anti-c, Anti-C Anti-Fya Anti-Jka, Anti-Jkb Anti-S
Tranfusion medecine: describe forward and reverse testing
Forward: determination of blood group using patient’s erythrocytes
Reverse: determination of blood group using patient’s serum
Both techniques are done and should correspond.
Name 1 situation where forward and reverse determination of blood group may not correspond?
Infants less than 9 months of age re: do not make isohemagglutinins but may carry maternal ones
Choice of RBC for patients with sickle cell anemia
Provide fully matched blood (D, C, E, c, e, K, Fya, Fyb, JKa, JKb)
Alternative: partially matched blood (D, C, E, K antigens)
Choice of RBC for patients with thalassemia
Usually not phenotypically matched re: very low incidence of alloantibodies, no crisis associated with hemolysis
Types of ABO incompatibility in HSCT
How are they managed?
MAJOR: recipient has Ab against donor RBCs; may lead to erythroid aplasia
RBCs removed from HSCT before infusion
MINOR: donor has Ab against recipient RBCs
Plasma is removed from HSCT before infusion
3 reasons for false positive DAT (other than auto- and allo-antibodies)
- Overcentrifugation or contaminated reagents
- Insufficient washing of patient’s RBCs
- Prolonged delay between centrifugation and testing
What causes febrile nonhemolytic reactions during transfusion?
Presence of cytokines and other pyrogens in the blood product, released by leucocytes and platelets (during storage, or during infusion)
Differential diagnosis of fever, during a transfusion?
- Febrile non-hemolytic reaction
- Acute hemolysis
- TRALI
- Sepsis from a contaminated unit
Delayed hemolytic reaction: typical clinical scenario
Anemia, hyperbilirubinemia 3-10 days after RBC transfusion